Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints.

Schmidt M, Arjomand-Wölkart K, Birkhäuser MH, Genazzani AR, Gruber DM, Huber J, Kölbl H, Kreft S, Leodolter S, Linsberger D, Metka M, Simoncini T, Vrabic Dezman L.

Gynecol Endocrinol. 2016 Jun;32(6):427-30. doi: 10.3109/09513590.2016.1152240. Epub 2016 Mar 4.

PMID:
26943176
2.

Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia.

Grimm C, Watrowski R, Baumühlner K, Natter C, Tong D, Wolf A, Zeillinger R, Leodolter S, Reinthaller A, Hefler L.

Gynecol Oncol. 2011 Jun 1;121(3):537-41. doi: 10.1016/j.ygyno.2011.02.019. Epub 2011 Mar 3.

PMID:
21376376
3.

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.

Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Hernandez-Avila M, Brown DR, Elbasha E, Muñoz N, Paavonen J, Haupt RM; FUTURE I Investigators.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):287-96. doi: 10.1158/1055-9965.EPI-10-0791.

4.

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S, Hesley TM, Barr E, Haupt R.

BMJ. 2010 Jul 20;341:c3493. doi: 10.1136/bmj.c3493.

5.

Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.

Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S, Joura EA, Ferris DG, Steben M, Brown DR, Elbasha EH, Paavonen J, Haupt RM; FUTURE I Investigators.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1585-94. doi: 10.1158/1055-9965.EPI-09-1235.

6.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
7.

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.

Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Hum Vaccin. 2009 Oct;5(10):696-704. Epub 2009 Oct 1.

PMID:
19855170
8.

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.

Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Dillner J, Joura EA, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Maansson R, Lu S, Vuocolo S, Hesley TM, Saah A, Barr E, Haupt RM.

Cancer Prev Res (Phila). 2009 Oct;2(10):868-78. doi: 10.1158/1940-6207.CAPR-09-0031. Epub 2009 Sep 29.

9.

Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology.

Marth C, Hiebl S, Oberaigner W, Winter R, Leodolter S, Sevelda P.

Int J Gynecol Cancer. 2009 Jan;19(1):94-102. doi: 10.1111/IGC.0b013e31819915cb.

PMID:
19258949
10.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.

Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Sings HL, James M, Hesley TM, Barr E.

J Infect Dis. 2009 Apr 1;199(7):926-35. doi: 10.1086/597307.

PMID:
19236279
11.

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.

Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, James M, Vuocolo S, Hesley TM, Barr E.

J Infect Dis. 2009 Apr 1;199(7):936-44. doi: 10.1086/597309.

PMID:
19236277
12.

Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.

Six L, Leodolter S, Sings HL, Barr E, Haupt R, Joura EA.

Wien Klin Wochenschr. 2008;120(21-22):666-71. doi: 10.1007/s00508-008-1093-3.

PMID:
19116707
13.

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch X, Dillner J, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Lu S, Vuocolo S, Hesley TM, Haupt RM, Barr E.

Vaccine. 2008 Dec 9;26(52):6844-51. doi: 10.1016/j.vaccine.2008.09.073. Epub 2008 Oct 16.

PMID:
18930097
14.

Expression of the human MTA1 gene in breast cell lines and in breast cancer tissues.

Tong D, Heinze G, Schremmer M, Schuster E, Czerwenka K, Leodolter S, Zeillinger R.

Oncol Res. 2007;16(10):465-70.

PMID:
18196870
15.

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J.

Lancet. 2007 May 19;369(9574):1693-702.

PMID:
17512854
16.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators.

N Engl J Med. 2007 May 10;356(19):1928-43.

17.

Phytoestrogens in clinical practice: a review of the literature.

Tempfer CB, Bentz EK, Leodolter S, Tscherne G, Reuss F, Cross HS, Huber JC.

Fertil Steril. 2007 Jun;87(6):1243-9. Epub 2007 May 9. Review.

PMID:
17490659
18.

Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.

Garland SM, Steben M, Hernandez-Avila M, Koutsky LA, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Esser MT, Vuocolo SC, Nelson M, Railkar R, Sattler C, Barr E; 012 Study Investigators.

Clin Vaccine Immunol. 2007 Jun;14(6):792-5. Epub 2007 Apr 11.

19.

The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells.

Schmid BC, Rezniczek GA, Fabjani G, Yoneda T, Leodolter S, Zeillinger R.

Breast Cancer Res Treat. 2007 Dec;106(3):333-42. Epub 2007 Feb 1.

PMID:
17268810
20.

[Ernst Wertheim, or the significance of the EBM of the cervical cancer].

Leodolter S.

Zentralbl Gynakol. 2006 Jun;128(3):97-103. German.

PMID:
16758373
21.

Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.

Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, Witt A, Leodolter S, Zeillinger R.

Clin Cancer Res. 2006 Apr 15;12(8):2442-8.

22.

Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.

Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K.

Gynecol Oncol. 2006 Oct;103(1):186-9. Epub 2006 Apr 3.

PMID:
16595146
23.

A common polymorphism within the steroid 5-alpha-reductase type 2 gene and timing of menopause in Caucasian women.

Huber A, Grimm C, Huber JC, Schneeberger C, Leodolter S, Reinthaller A, Tempfer CB, Hefler LA.

Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):221-5. Epub 2005 Dec 2.

PMID:
16325991
24.

A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.

Six L, Grimm C, Leodolter S, Tempfer C, Zeillinger R, Sliutz G, Speiser P, Reinthaller A, Hefler LA.

Gynecol Oncol. 2006 Mar;100(3):506-10. Epub 2005 Oct 6.

PMID:
16214204
25.

Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women.

Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, Koelbl H, Heinze G, Reinthaller A, Tong-Cacsire D, Tempfer C, Zeillinger R.

Clin Cancer Res. 2005 Aug 15;11(16):5718-21.

26.

HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.

Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, Fischer MB, Jakesz R, Zeillinger R.

Oncol Rep. 2005 Sep;14(3):737-41.

PMID:
16077985
27.

Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.

Tringler B, Grimm C, Sliutz G, Leodolter S, Speiser P, Reinthaller A, Hefler LA.

Gynecol Oncol. 2005 Oct;99(1):80-3.

PMID:
16009408
28.

The influence of a Vitamin D receptor gene polymorphism on the timing of female reproductive functions in humans.

Grimm C, Tempfer CB, Walch K, Reinthaller A, Tomovski C, Huber JC, Leodolter S, Hefler LA.

Maturitas. 2005 Jun 16;51(2):135-9.

PMID:
15917153
29.

Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience.

Floery D, Helbich TH, Riedl CC, Jaromi S, Weber M, Leodolter S, Fuchsjaeger MH.

Invest Radiol. 2005 Jun;40(6):328-35.

PMID:
15905718
30.

Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.

Hefler LA, Sliutz G, Leodolter S, Speiser P, Joura E, Reinthaller A, Kohlberger P.

Gynecol Oncol. 2005 Jun;97(3):904-7.

PMID:
15894354
31.

Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women.

Hefler LA, Grimm C, Heinze G, Schneeberger C, Mueller MW, Muendlein A, Huber JC, Leodolter S, Tempfer CB.

Hum Reprod. 2005 May;20(5):1422-7. Epub 2005 Mar 17.

PMID:
15774541
32.

Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.

Bodner-Adler B, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K.

Gynecol Oncol. 2005 Jan;96(1):62-6.

PMID:
15589581
33.

Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.

Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, Leodolter S, Schneeberger C, Mueller MW, Muendlein A, Koelbl H.

Cancer. 2004 Jul 15;101(2):264-9.

34.

Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.

Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB.

Gynecol Oncol. 2004 Jun;93(3):686-90.

PMID:
15196865
35.

To butterfly or to needle: the pilot phase.

Hefler L, Grimm C, Leodolter S, Tempfer C.

Ann Intern Med. 2004 Jun 1;140(11):935-6. No abstract available.

PMID:
15172916
37.

Christian Doppler and the influence of his work on modern medicine.

Kainberger F, Leodolter S.

Wien Klin Wochenschr. 2004 Feb 28;116(4):107-9. No abstract available.

PMID:
15038399
38.

CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia.

Schmid BC, Rudas M, Rezniczek GA, Leodolter S, Zeillinger R.

Breast Cancer Res Treat. 2004 Apr;84(3):247-50.

PMID:
15026622
39.

Loss of heterozygosity on chromosome 13q: suggestion of a candidate tumor suppressor gene in sporadic breast cancer.

Tong D, Schuster E, Czerwenka K, Leodolter S, Zeillinger R.

Breast Cancer Res Treat. 2004 Jan;83(2):143-8.

PMID:
14997045
40.

A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis.

Grimm C, Berger I, Tomovski C, Zeillinger R, Concin N, Leodolter S, Koelbl H, Tempfer CB, Hefler LA.

Gynecol Oncol. 2004 Mar;92(3):936-40.

PMID:
14984963
41.

Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.

Schmid BC, Rudas M, Fabjani G, Speiser P, Kaserer K, Leodolter S, Zeillinger R.

Oncol Rep. 2003 Nov-Dec;10(6):1981-5.

PMID:
14534730
42.

MMP-1 and MMP-2 expression in uterine leiomyosarcoma and correlation with different clinicopathologic parameters.

Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K.

J Soc Gynecol Investig. 2003 Oct;10(7):443-6.

PMID:
14519487
43.

Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy.

Nather A, Mayerhofer K, Grimm C, Hefler L, Leodolter S, Obermair A, Joura EA.

Anticancer Res. 2003 May-Jun;23(3C):2991-4.

PMID:
12926151
44.

Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.

Tong D, Volm T, Eberhardt E, Krainer M, Leodolter S, Kreienberg R, Zeillinger R.

Oncol Rep. 2003 Sep-Oct;10(5):1551-3.

PMID:
12883740
45.

[Anterior sacral meningocele in pregnancy].

Nather A, Lomoschitz F, Leodolter S.

Wien Klin Wochenschr. 2003 Jun 24;115(11):398-400. German.

PMID:
12879738
46.

An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.

Hefler LA, Grimm C, Ackermann S, Malur S, Radjabi-Rahat AR, Leodolter S, Beckmann MW, Zeillinger R, Koelbl H, Tempfer CB.

Cancer Res. 2003 Jun 15;63(12):3066-8.

47.

Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia.

Kohlberger P, Beneder Ch, Horvat R, Leodolter S, Breitenecker G.

Gynecol Oncol. 2003 Jun;89(3):391-4.

PMID:
12798700
48.

Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines.

Concin N, Zeillinger C, Tong D, Stimpfl M, König M, Printz D, Stonek F, Schneeberger C, Hefler L, Kainz C, Leodolter S, Haas OA, Zeillinger R.

Breast Cancer Res Treat. 2003 May;79(1):37-46.

PMID:
12779080
49.

Bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.

Bodner K, Bodner-Adler B, Czerwenka K, Hudelist G, Kimberger O, Leodolter S, Mayerhofer K.

Wien Klin Wochenschr. 2003 Mar 31;115(5-6):191-5.

PMID:
12741081
50.

Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.

Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K.

Anticancer Res. 2003 Jan-Feb;23(1B):729-32.

PMID:
12680175

Supplemental Content

Loading ...
Support Center